Trial intelligence / Profile preview

Advil Dual Action Liquid Filled Capsules vs Caplets Bioequivalence Study

NCT06802185Phase 1Completed

Sponsor
Haleon
Start
Jan 2025
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of ibuprofen and acetaminophen in pain (4 arms), sponsored by Haleon. Primary endpoints: Maximum Observed Post-dose Concentration at 24 hours, Area Under the Plasma Concentration Versus Time Curve from time 0 to last measurable time point at 24 hours and 1 more. Started Jan 2025; status: completed.

02

Drugs

ibuprofenacetaminophen
03

Conditions

pain

Beyond the preview

Go deeper on NCT06802185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06802185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call